SpiroChem is pleased to announce its participation in Discovery on Target 2026, taking place from September 28 to October 1, 2026 in Boston, United States.
Discovery on Target brings together scientists and industry professionals working across drug discovery, therapeutic innovation and enabling technologies. The four-day program will address a broad range of topics including target identification, lead generation, screening strategies, AI/ML applications and emerging drug modalities.
The conference will feature dedicated sessions covering small molecules, peptides, biologics, conjugates, radioligand therapies and innovative discovery technologies, providing a platform for scientific exchange across multiple areas of pharmaceutical research.
Attending for SpiroChem:
Thomas Fessard, PhD – CEO
During the conference, SpiroChem will engage with the drug discovery community and exchange perspectives on current scientific challenges, new technologies and opportunities for collaboration.
We look forward to participating in Discovery on Target 2026 and connecting with researchers and industry professionals advancing the next generation of drug discovery.
